Location · Rockford, IL
Clinical trials in Rockford, IL
8 recruiting studies have a site in Rockford, and 0 of them accept healthy volunteers.
8 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 3
A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy
Takeda
- Location
- Rockford, IL + 42 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 4
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
Takeda
- Location
- Rockford, IL + 77 other US sites
- Eligibility basics
- Ages 18–80
- Recruiting
Use of the REGENETEN™ Bioinductive Implant System in High Grade Partial-thickness Tears
Smith & Nephew, Inc.
- Location
- Rockford, IL + 2 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
A Phase III Renal Outcomes and Cardiovascular Mortality Study to Investigate the Efficacy and Safety of Baxdrostat in Combination With Dapagliflozin in Participants With Chronic Kidney Disease and High Blood Pressure
AstraZeneca
- Location
- Rockford, IL + 104 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Safety and Efficacy of J147 in Acute Ischemic Stroke
Abrexa Pharmaceuticals, Inc.
- Location
- Rockford, IL
- Eligibility basics
- Ages 18–90
- Recruiting
Carotid Implants for PreveNtion of STrokE ReCurrEnce From Large Vessel Occlusion in Atrial Fibrillation Patients Treated With Oral Anticoagulation
Javelin Medical
- Location
- Rockford, IL + 3 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Study of DONQ52 in Active Celiac Disease
Chugai Pharmaceutical
- Location
- Rockford, IL + 57 other US sites
- Eligibility basics
- Ages 18–75
- RecruitingPhase 3
Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
Anthos Therapeutics, Inc.
- Location
- Rockford, IL + 131 other US sites
- Eligibility basics
- Ages 65+